These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22617279)

  • 21. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects.
    Seppo L; Jauhiainen T; Poussa T; Korpela R
    Am J Clin Nutr; 2003 Feb; 77(2):326-30. PubMed ID: 12540390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjects.
    Yamamura S; Morishima H; Kumano-go T; Suganuma N; Matsumoto H; Adachi H; Sigedo Y; Mikami A; Kai T; Masuyama A; Takano T; Sugita Y; Takeda M
    Eur J Clin Nutr; 2009 Jan; 63(1):100-5. PubMed ID: 17851460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects.
    van der Zander K; Bots ML; Bak AA; Koning MM; de Leeuw PW
    Am J Clin Nutr; 2008 Dec; 88(6):1697-702. PubMed ID: 19064533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men.
    Mizushima S; Ohshige K; Watanabe J; Kimura M; Kadowaki T; Nakamura Y; Tochikubo O; Ueshima H
    Am J Hypertens; 2004 Aug; 17(8):701-6. PubMed ID: 15288885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies.
    van Mierlo LA; Koning MM; van der Zander K; Draijer R
    Am J Clin Nutr; 2009 Feb; 89(2):617-23. PubMed ID: 19106238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chanson-Rolle A; Aubin F; Braesco V; Hamasaki T; Kitakaze M
    PLoS One; 2015; 10(11):e0142235. PubMed ID: 26536628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects.
    de Leeuw PW; van der Zander K; Kroon AA; Rennenberg RM; Koning MM
    Blood Press; 2009; 18(1-2):44-50. PubMed ID: 19247842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG; Pearce GL; Danoff TM
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives.
    Inoue K; Shirai T; Ochiai H; Kasao M; Hayakawa K; Kimura M; Sansawa H
    Eur J Clin Nutr; 2003 Mar; 57(3):490-5. PubMed ID: 12627188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial.
    Cicero AF; Rosticci M; Veronesi M; Bacchelli S; Strocchi E; Melegari C; Grandi E; Borghi C
    J Med Food; 2010 Dec; 13(6):1363-8. PubMed ID: 21091250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects.
    van der Zander K; Jäkel M; Bianco V; Koning MM
    J Hum Hypertens; 2008 Nov; 22(11):804-6. PubMed ID: 18528405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactopeptides and human blood pressure.
    Geleijnse JM; Engberink MF
    Curr Opin Lipidol; 2010 Feb; 21(1):58-63. PubMed ID: 19884823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials.
    Qin LQ; Xu JY; Dong JY; Zhao Y; van Bladeren P; Zhang W
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):395-402. PubMed ID: 23566677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
    Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.